<DOC>
	<DOCNO>NCT01690052</DOCNO>
	<brief_summary>The main objective : 1 ) To determine efficacy cevimeline pilocarpine secretion saliva patient xerostomia , 2 ) To compare side-effects treatment xerostomia cevimeline pilocarpine .</brief_summary>
	<brief_title>Efficacy Cevimeline Versus Pilocarpine Secretion Saliva</brief_title>
	<detailed_description>Pilocarpine cholinergic agonist predominant muscarinic action.As , act muscarinic-cholinergic receptor find throughout body promotes fluid secretion . Due , one main side-effects pilocarpine increase amount sweating . Thus , salivary gland stimulate , body 's exocrine gland ' production heighten . On hand , cevimeline drug high affinity specific muscarinic receptor ( M3 ) locate lachrymal salivary gland epithelium . At least theory , cevimeline produce less side effect compare pilocarpine high affinity muscarinic receptor locate salivary gland . A limited number human clinical trial efficacy cevimeline pilocarpine increase production saliva side effect perform conclusive result . The main purpose study determine efficacy cevimeline pilocarpine secretion saliva patient xerostomia , compare side-effects two medication .</detailed_description>
	<mesh_term>Xerostomia</mesh_term>
	<mesh_term>Pilocarpine</mesh_term>
	<mesh_term>Cevimeline</mesh_term>
	<criteria>Potential candidate diagnosis moderatesevere xerostomia identify Oral Medicine Clinic University Of Kentucky College Of Dentistry , self referral response IRB approve study announcement . Enrollment required clinical evidence oral lesion , subjective perception dry mouth le 2 mL saliva collect 5 minute without stimulation . Exclusion criterion include patient non control chronic obstructive pulmonary disease ( COPD ) , depression , asthma , cardiac arrhythmia , glaucoma , current use medication interaction cevimeline pilocarpine .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>dry mouth</keyword>
</DOC>